MedTrace Logo

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

NCT00120211 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 855

Last updated 2011-10-13

No results posted yet for this study

Summary

This trial compares the use of 6 fractions versus the standard 5 fractions of radiotherapy used in the treatment of head and neck cancer.

Conditions

Interventions

RADIATION

Accelerated Radiotherapy Fractionation

Radiation Therapy 6 fractions per week

RADIATION

Accelerated Radiotherapy Fractionation

Radiotherapy 5 fractions per week

Sponsors & Collaborators

  • International Atomic Energy Agency

    lead OTHER_GOV

Principal Investigators

  • Eduardo Rosenblatt, M.D. · International Atomic Energy Agency (IAEA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-09-30
Primary Completion
2006-05-31
Completion
2006-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120211 on ClinicalTrials.gov